|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Burki TK: Cervical cancer: Screening and
risk with age. Lancet Oncol. 15:e1072014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Waggoner SE: Cervical cancer. Lancet.
361:2217–2225. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shen J, Stass SA and Jiang F: MicroRNAs as
potential biomarkers in human solid tumors. Cancer Lett.
329:125–136. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Y, Wang Y and Wang J: MicroRNA-584
inhibits cell proliferation and invasion in non-small cell lung
cancer by directly targeting MTDH. Exp Ther Med. 15:2203–2211.
2018.PubMed/NCBI
|
|
7
|
Zheng L, Chen Y, Ye L, Jiao W, Song H, Mei
H, Li D, Yang F, Li H, Huang K and Tong Q: miRNA-584-3p inhibits
gastric cancer progression by repressing Yin Yang 1-facilitated
MMP-14 expression. Sci Rep. 7:89672017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Q, Li Z, Wei S, Wang W, Chen Z, Zhang
L, Chen L, Li B, Sun G, Xu J, et al: Overexpression of miR-584-5p
inhibits proliferation and induces apoptosis by targeting WW
domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
J Exp Clin Cancer Res. 36:592017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Orlandella FM, Di Maro G, Ugolini C,
Basolo F and Salvatore G: TWIST1/miR-584/TUSC2 pathway induces
resistance to apoptosis in thyroid cancer cells. Oncotarget.
7:70575–70588. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xue H, Guo X, Han X, Yan S, Zhang J, Xu S,
Li T, Guo X, Zhang P, Gao X, et al: MicroRNA-584-3p, a novel tumor
suppressor and prognostic marker, reduces the migration and
invasion of human glioma cells by targeting hypoxia-induced ROCK1.
Oncotarget. 7:4785–4805. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiang J, Wu Y, Li DS, Wang ZY, Shen Q, Sun
TQ, Guan Q and Wang YJ: miR-584 suppresses invasion and cell
migration of thyroid carcinoma by regulating the target oncogene
ROCK1. Oncol Res Treat. 38:436–440. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang XP, Deng XL and Li LY: MicroRNA-584
functions as a tumor suppressor and targets PTTG1IP in glioma. Int
J Clin Exp Pathol. 7:8573–8582. 2014.PubMed/NCBI
|
|
13
|
Ueno K, Hirata H, Shahryari V, Chen Y,
Zaman MS, Singh K, Tabatabai ZL, Hinoda Y and Dahiya R: Tumor
suppressor microRNA-584 directly targets oncogene Rock-1 and
decreases invasion ability in human clear cell renal cell
carcinoma. Br J Cancer. 104:308–315. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Wang B, Fang M, Guo F and Cui M:
Identification of microRNAs and target genes involved in serous
ovarian carcinoma and their influence on survival. Eur J Gynaecol
Oncol. 35:655–661. 2014.PubMed/NCBI
|
|
15
|
Didiasova M, Schaefer L and Wygrecka M:
Targeting GLI transcription factors in cancer. Molecules. 23(pii):
E10032018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mastrangelo E and Milani M: Role and
inhibition of GLI1 protein in cancer. Lung Cancer. 9:35–43.
2018.PubMed/NCBI
|
|
17
|
Zhao D and Cui Z: MicroRNA-361-3p
regulates retinoblastoma cell proliferation and stemness by
targeting hedgehog signaling. Exp Ther Med. 17:1154–1162.
2019.PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hasanzadeh M, Movahedi M, Rejali M, Maleki
F, Moetamani-Ahmadi M, Seifi S, Hosseini Z, Khazaei M, Amerizadeh
F, Ferns GA, et al: The potential prognostic and therapeutic
application of tissue and circulating microRNAs in cervical cancer.
J Cell Physiol. 234:1289–1294. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Abdelfattah N, Rajamanickam S, Panneerdoss
S, Timilsina S, Yadav P, Onyeagucha BC, Garcia M, Vadlamudi R, Chen
Y, Brenner A, et al: MiR-584-5p potentiates vincristine and
radiation response by inducing spindle defects and DNA damage in
medulloblastoma. Nat Commun. 9:45412018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sabol M, Trnski D, Musani V, Ozretic P and
Levanat S: Role of GLI transcription factors in pathogenesis and
their potential as new therapeutic targets. Int J Mol Sci. 19(pii):
E25622018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Skoda AM, Simovic D, Karin V, Kardum V,
Vranic S and Serman L: The role of the Hedgehog signaling pathway
in cancer: A comprehensive review. Bosn J Basic Med Sci. 18:8–20.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chaudary N, Pintilie M, Hedley D, Fyles
AW, Milosevic M, Clarke B, Hill RP and Mackay H: Hedgehog pathway
signaling in cervical carcinoma and outcome after chemoradiation.
Cancer. 118:3105–3115. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Çalışkan M, Güler H and Bozok Çetintaş V:
Current updates on microRNAs as regulators of chemoresistance.
Biomed Pharmacother. 95:1000–1012. 2017. View Article : Google Scholar : PubMed/NCBI
|
